Patents by Inventor Eric P. Berg

Eric P. Berg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10967104
    Abstract: A stent system comprising zero or more inner stents inserted into an outer stent. The inner stents and outer stent are separated and/or encapsulated by a protein-based material of a protein matrix and/or a set biocoacervate, each comprising one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: April 6, 2021
    Assignee: PETVIVO HOLDINGS, INC.
    Inventors: David B. Masters, Eric P. Berg
  • Publication number: 20210038764
    Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.
    Type: Application
    Filed: October 28, 2020
    Publication date: February 11, 2021
    Applicant: PETVIVO HOLDINGS, INC.
    Inventors: David B. Masters, Eric P. Berg
  • Patent number: 10850006
    Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: December 1, 2020
    Assignee: PETVIVO HOLDINS, INC.
    Inventors: David B. Masters, Eric P. Berg
  • Publication number: 20190125928
    Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.
    Type: Application
    Filed: May 16, 2018
    Publication date: May 2, 2019
    Inventors: David B. Masters, Eric P. Berg
  • Publication number: 20190014766
    Abstract: A fishing system is disclosed. In one aspect, the fishing system includes a first fishing line segment terminating with a hook and a second fishing line segment terminating with a sinker. An attachment point can also be provided, wherein a first eyelet of the attachment point is slidably arranged on the first fishing line segment and a second eyelet of the attachment point is attached to the second fishing line segment. The fishing system can also include an immovable stopper attached to the first fishing line segment and a rigid or non-collapsing flexible tube spaced between the hook and the immovable stopper. In one aspect, the hook, stopper, and tube can move distally away from the first eyelet. The fishing system can also include a spherical ball spacer situated between the stopper and the first eyelet.
    Type: Application
    Filed: July 11, 2018
    Publication date: January 17, 2019
    Inventor: Eric P. Berg
  • Publication number: 20180193534
    Abstract: A stent system comprising zero or more inner stents inserted into an outer stem. The inner stems and outer stent are separated and/or encapulated by a protein-based material of a protein matrix and/or a set biocoacervate, each comprising one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents.
    Type: Application
    Filed: August 28, 2017
    Publication date: July 12, 2018
    Inventors: David B. Masters, Eric P. Berg
  • Patent number: 9999705
    Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: June 19, 2018
    Assignee: Gel-Del Technologies, Inc.
    Inventors: David B. Masters, Eric P. Berg
  • Publication number: 20160158411
    Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.
    Type: Application
    Filed: August 17, 2015
    Publication date: June 9, 2016
    Inventors: David B. Masters, Eric P. Berg
  • Patent number: 9107937
    Abstract: Biomaterials and the related methods of making and using biomaterials for wound treatment. The biomaterial defines an amorphous material that is crosslinked with one or more crosslinking agents an includes aggregated complexes having homogenously distributed biocoacervated components. The biocoacervated components include one or more soluble or solubilized primary proteins combined with one or more glycosaminoglycans and one or more biocompatible solvents. The biomaterial can be utilized by administering the biomaterial to a wound.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: August 18, 2015
    Assignee: Gel-Del Technologies, Inc.
    Inventors: David B. Masters, Eric P. Berg
  • Publication number: 20140330252
    Abstract: The containment and fixation system of the present invention generally includes a biomatrix sleeve, biomatrix particles or combinations thereof made of a biomatrix material. The biomatrix material is comprised of one or more biocompatible proteins and one or more biocompatible solvents. The biomatrix material utilized in the sleeve and/or particles may also include one or more pharmacologically active agents like therapeutic biochemicals such as a bone mending biochemical (e.g. hydroxyapatite) or an angiogenic growth factor (e.g. BMP).
    Type: Application
    Filed: January 7, 2014
    Publication date: November 6, 2014
    Inventors: David B. Masters, Eric P. Berg
  • Publication number: 20140107227
    Abstract: The present invention relates to mucoadhesive drug delivery devices and their methods of preparation and use. More specifically the present invention relates to mucoadhesive drug delivery devices comprising one or more biocompatible purified proteins combined with one or more biocompatible solvents and one or more mucoadhesive agents. The mucoadhesive drug delivery devices may also include one or more pharmacologically active agents. The drug delivery devices of the present invention adhere to mucosal tissue, thereby providing a vehicle for delivery of the pharmacologically active agent(s) through such tissue.
    Type: Application
    Filed: September 10, 2013
    Publication date: April 17, 2014
    Inventors: David B. Masters, Eric P. Berg
  • Patent number: 8529939
    Abstract: The present invention relates to mucoadhesive drug delivery devices and their methods of preparation and use. More specifically the present invention relates to mucoadhesive drug delivery devices comprising one or more biocompatible purified proteins combined with one or more biocompatible solvents and one or more mucoadhesive agents. The mucoadhesive drug delivery devices may also include one or more pharmacologically active agents. The drug delivery devices of the present invention adhere to mucosal tissue, thereby providing a vehicle for delivery of the pharmacologically active agent(s) through such tissue.
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: September 10, 2013
    Assignee: Gel-Del Technologies, Inc.
    Inventors: David B. Masters, Eric P. Berg
  • Patent number: 8465537
    Abstract: A stent system having zero or more inner stents inserted into an outer stent. The inner stents and outer stent are separated and/or encapsulated by a protein-based material of a protein matrix and/or a set biocoacervate, each one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: June 18, 2013
    Assignee: Gel-Del Technologies, Inc.
    Inventors: David B. Masters, Eric P. Berg
  • Patent number: 8420153
    Abstract: A coating with antimicrobial agents for use with medical devices. In one approach, a related method involves coating high temperature vulcanized silicone material with a room temperature vulcanized dispersion.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: April 16, 2013
    Assignee: Mentor Worldwide LLC
    Inventors: Eric P. Berg, Rita Stella
  • Patent number: 8419793
    Abstract: A coating with antimicrobial agents for use with medical devices. In one approach, a related method involves coating high temperature vulcanized silicone material with a room temperature vulcanized dispersion.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: April 16, 2013
    Assignee: Mentor Worldwide LLC
    Inventors: Eric P. Berg, Rita Stella
  • Publication number: 20120282300
    Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.
    Type: Application
    Filed: March 30, 2012
    Publication date: November 8, 2012
    Applicant: GEL-DEL TECHNOLOGIES, INC.
    Inventors: David B. Masters, Eric P. Berg
  • Patent number: 8153591
    Abstract: The present invention relates to protein biocoacervates and biomaterials and the methods of making and using protein biocoacervates and biomaterials. More specifically the present invention relates to protein biocoacervates and biomaterials that may be utilized for various medical applications including, but not limited to, drug delivery devices for the controlled release of pharmacologically active agents, coated medical devices (e.g. stents, valves . . . ), vessels, tubular grafts, vascular grafts, wound healing devices including protein suture biomaterials and biomeshes, dental plugs and implants, skin/bone/tissue grafts, tissue fillers, protein biomaterial adhesion prevention barriers, cell scaffolding and other biocompatible biocoacervate or biomaterial devices.
    Type: Grant
    Filed: August 26, 2004
    Date of Patent: April 10, 2012
    Assignee: Gel-Del Technologies, Inc.
    Inventors: David B. Masters, Eric P. Berg
  • Publication number: 20110118818
    Abstract: A stent system comprising zero or more inner stents inserted into an outer stent. The inner stents and outer stent are separated and/or encapsulated by a protein-based material of a protein matrix and/or a set biocoacervate, each comprising one or more biocompatible proteins and one or more biocompatible solvents. The protein-based material may also include one or more carbohydrates and one or more pharmacologically active agents.
    Type: Application
    Filed: June 17, 2005
    Publication date: May 19, 2011
    Inventors: David B. Masters, Eric P. Berg
  • Patent number: 7811317
    Abstract: A method for making an intravascular stent by applying to the body of a stent a solution which includes a solvent, a polymer dissolved in the solvent and a therapeutic substance dispersed in the solvent and then evaporating the solvent. The inclusion of a polymer in intimate contact with a drug on the stent allows the drug to be retained on the stent during expansion of the stent and also controls the administration of drug following implantation. The adhesion of the coating and the rate at which the drug is delivered can be controlled by the selection of an appropriate bioabsorbable or biostable polymer and the ratio of drug to polymer in the solution. By this method, drugs such as dexamethasone can be applied to a stent, retained on a stent during expansion of the stent and elute at a controlled rate.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: October 12, 2010
    Assignee: Medtronic, Inc.
    Inventors: Eric P. Berg, Ronald J. Tuch, Michael Dror, Rodney G. Wolff
  • Publication number: 20100198350
    Abstract: A coating with antimicrobial agents for use with medical devices. In one approach, a related method involves coating high temperature vulcanized silicone material with a room temperature vulcanized dispersion.
    Type: Application
    Filed: March 12, 2010
    Publication date: August 5, 2010
    Applicant: MENTOR WORLDWIDE LLC
    Inventors: Eric P. Berg, Rita Stella